Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 4

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency

Total article views   Abstract views HTML views PDF downloads Totals
14,317 Dovepress* 9,657 1,033+ 2,103 10,690
PubMed Central* 9 3,618 608 3,627
Totals 9,666 4,651 2,711 14,317
*Since 31 May 2011
+Since July 2016

View citations on PubMed Central and Google Scholar